EWM
IMGN

Elite Wealth Management’s Immunogen Inc IMGN Stock Holding History

Elite Wealth Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-51
Closed -$1K – 688
2013
Q4 		$1K Buy
+51
New +$784 ﹤0.01% 831

Other funds holding IMGN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elite Wealth Management's IMGN Position: Q1 2014 in Review

Elite Wealth Management sold out of Immunogen Inc (IMGN) in Q1 2014, closing a stake of 51 shares — an estimated $1K sold.

Elite Wealth Management first reported a position in IMGN in Q4 2013 and held it in 1 quarter. The position peaked at $1K in Q4 2013. 142 funds tracked by Wall St. Rank hold IMGN as of Q1 2014.

  • Elite Wealth Management reported no remaining Immunogen Inc position as of Q1 2014 after selling out during the quarter.
  • Elite Wealth Management sold 51 Immunogen Inc shares in Q1 2014, an estimated $1K.
  • Elite Wealth Management first reported a position in Immunogen Inc in Q4 2013 and held it in 1 quarter.
  • Elite Wealth Management's Immunogen Inc position peaked at $1K in Q4 2013.
  • 142 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2014.

Based on Elite Wealth Management's 13F filing for Q1 2014, filed 23 Nov 2016.